Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Novel Algorithms Allow Automated Monitoring of Individual Cell-to-Cell Interactions

By LabMedica International staff writers
Posted on 25 Aug 2015
A novel combination of microscopy, time-lapse video recording, and analytical algorithms enables tracking of individual cell-to-cell interactions, which will boost research towards cancer immunotherapy treatments.

The technique, Time-lapse Imaging Microscopy in Nanowell Grids (TIMING) was developed by investigators at the University of Houston (TX, USA) and their colleagues at the University of Texas M.D. More...
Anderson Cancer Center. Studies using this method were carried out using fluorescently labeled human T-cells, natural killer cells (NK), and various target cells (NALM6, K562, EL4), which were co-incubated on polydimethylsiloxane nanowell arrays and imaged using multichannel time-lapse microscopy.

Novel cell segmentation and tracking algorithms accounted for cell variability and exploited the nanowell confinement property to increase the yield of correctly analyzed nanowells from 45% (existing algorithms) to 98% for wells containing one effector and a single target, enabling automated quantification of cell locations, morphologies, movements, interactions, and deaths without the need for manual proofreading.

Automated analysis of recordings from 12 different experiments published in the June 9, 2015, online edition of the journal Bioinformatics demonstrated automated nanowell delineation accuracy greater than 99%, automated cell segmentation accuracy greater than 95%, and automated cell tracking accuracy of 90%, with default parameters, despite variations in illumination, staining, imaging noise, cell morphology, and cell clustering.

Example analysis revealed that NK cells efficiently discriminated between live and dead targets by altering the duration of conjugation. The data also demonstrated that cytotoxic cells displayed higher motility than non-killers, both before and during contact.

"We have developed a game-changing piece of software that can accurately analyze an entire grid of nanowell videos and make quantitative measurements," said senior author Dr. Badri Roysam, professor of electrical and computer engineering at the University of Houston. "It is essentially the combination of a supermicroscope and a supercomputer to screen cell-cell interactions on a large scale. The proposed algorithms dramatically improved the yield and accuracy of the automated analysis to a level at which the automatically generated cellular measurements can be utilized for biological studies directly, with little/no editing."

Related Links:

University of Houston
University of Texas M.D. Anderson Cancer Center



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Turbidimetric Control
D-Dimer Turbidimetric Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.